Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

for
Neurotrophic Keratopathy
Location: Seatle WA, Portland OR, Medford OR, Loma Linda CA,
Sponsor: ReGenTree, LLC

Sex: All

Age: 18+

Code: NCT05555589

Phase3, Recruiting

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

for
Prostate Cancer
Location: Seattle WA
Sponsor: VA Puget Sound Health Care System

Sex: Male

Age: 40 - 70+

Code: NCT00486499

Phase3, Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for
Hepatocellular Carcinoma (HCC)
Location: Seattle WA, Orange CA, Phoenix AZ, Tucson AZ, Omaha NE,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT06726161

Phase1, Phase2, Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Seattle WA, Bremerton WA, Portland OR, Spokane WA,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Seattle WA, Salt Lake City UT, Irvine CA, Omaha NE,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT05477576

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment

for
Alcohol Use Disorder, Unhealthy Alcohol Use
Location: Seattle WA
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT06318026

Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Seattle WA, Las Vegas NV, Los Angeles CA, Cerritos CA,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase1, Phase2, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Seattle WA, Portland OR, Spokane WA, Lewiston ID,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

for
Hormone-refractory Prostate Cancer
Location: Seattle WA, Palo Alto CA, Orange CA, Houston TX,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT05997615

Phase1, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Seattle WA, Tacoma WA, Portland OR, San Francisco CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

TVMR With the INNOVALVE System Trial - Early Feasibility Study

for
Mitral Valve Regurgitation (Degenerative or Functional)
Location: Seattle WA, Portland OR, Palo Alto CA, Los Angeles CA,
Sponsor: Edwards Lifesciences

Sex: All

Age: 18+

Code: NCT04919980

Recruiting

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

for
Relapsed or Refractory Hematologic Malignancies
Location: Seattle WA, Fairway KS, Lafayette IN, Washington DC,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03838926

Phase1, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Renton WA, Portland OR, Kennewick WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

for
Primary Myelofibrosis,
Location: Seattle WA, Vancouver, Ann Arbor MI, Houston TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06517875

Phase2, Recruiting

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Seattle WA, Rochester MN, Rochester NY, Boston MA
Sponsor: Enterome

Sex: All

Age: 18+

Code: NCT04669171

Phase1, Phase2, Recruiting

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

for
AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Seattle WA, Denver CO, Gilbert AZ, Dallas TX, Tyler TX,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04358393

Phase1, Phase2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Seattle WA, Mount Vernon WA, Portland OR, Eugene OR,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

for
Sarcoma
Location: Seattle WA, Santa Monica CA, Pittsburgh PA,
Sponsor: CBA Research

Sex: All

Age: 18+

Code: NCT03002805

Phase1, Recruiting